Lilly FoundayoBeyond's analysis on Lilly Foundayo2026-09-29 — Lilly's oral Foundayo outperforms oral semaglutide in weight loss and A1C reduction for type 2 diabetesRecent news mentioning Lilly Foundayo2026-09-29 — Lilly's Foundayo (orforglipron) 17.2 mg showed greater weight loss and A1C reduction than oral semaglutide 25 mg among adults with type 2 diabetes in a new indirect treatment comparisonAppears alongsideA1CBrowse the full archive →